CCR8 inhibitors
US7329755B2 · kind B2 · utility
9Cited by
9References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2003 |
| Grant date | Feb 12, 2008 |
| Priority date | — |
| Expiry date | Aug 11, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed is an inhibitor of CCR8 that is represented by Structural Formula (I):Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier or diluent and a CCR8 inhibitor represented by Structural Formula (I). Also disclosed is a method of treating inflammatory disorders in a subject by administering a CCR8 inhibitor to the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.